You are here

Adipose Clinical Trials

Comment

Discuss
Conditions:   Critical Limb Ischemia (CLI);   Diabetes
Intervention:   Drug: Autologous adipose derived mesenchymal stem cells
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas
Completed - verified November 2014
Conditions:   Graft Versus Host Disease;   Chronic and Expanded Graft Versus Host Disease;   Immune System Diseases
Interventions:   Other: Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.;   Other: Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas
Completed - verified November 2016
Condition:   Overweight
Intervention:   Procedure: Cell Culture
Sponsor:   University of Zurich
Completed - verified June 2013
Conditions:   Crohn's Disease;   Anal Fistula
Intervention:   Drug: Cx601
Sponsor:   Cellerix
Completed - verified June 2011
Condition:   Crohn Disease
Intervention:   Other: Autologous mesenchymal stem cells
Sponsor:   Clinica Universidad de Navarra, Universidad de Navarra
Completed - verified November 2016
Conditions:   Peripheral Vascular Diseases;   Cardiovascular Diseases
Intervention:   Biological: Expanded autologous ASCs
Sponsors:   University Hospital, Toulouse;   French Blood Establishment (Midi-Pyrénées);   Clinical Research Center, Toulouse;   Centre National de la Recherche Scientifique, France
Completed - verified May 2017
Conditions:   Autoimmune Diseases;   Immune System Diseases;   Demyelinating Diseases;   Nervous System Diseases;   Demyelinating Autoimmune Diseases, CNS;   Autoimmune Diseases of the Nervous System
Interventions:   Other: Autologous mesenchymal stem cells from adipose tissue.;   Other: Autologous mesenchymal stem cells from adipose tissue.
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Carlos III Health Institute
Completed - verified February 2015
Condition:   Crohn's Fistula
Intervention:   Biological: ADIPOPLUS
Sponsor:   Anterogen Co., Ltd.
Completed - verified March 2012
Condition:   Fecal Incontinence
Intervention:   Biological: ANT-SM
Sponsor:   Anterogen Co., Ltd.
Terminated - verified March 2011
Conditions:   Rectovaginal Fistula;   Crohn Disease
Intervention:   Drug: Expanded allogenic adipose-derived adult stem cells
Sponsor:   Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
Completed - verified January 2012

Pages